This article reports on the dosimetric properties of a new N-isopropylacrylamide, high %T, polymer gel formulation (19.5%T, 23%C), optimized for x-ray computed tomography (CT) polymer gel dosimetry (PGD). In addition, a new gel calibration technique is introduced together with an intensity-modulated radiation therapy (IMRT) treatment validation as an example of a clinical application of the new gel dosimeter. The dosimetric properties investigated include the temporal stability, spatial stability, batch reproducibility and dose rate dependence. The polymerization reaction is found to stabilize after 15 h post-irradiation. Spatial stability investigations reveal a small overshoot in response for gels imaged later than 36 h post-irradiation. Based on these findings, it is recommended that the new gel formulation be imaged between 15-36 h after irradiation. Intra- and inter-batch reproducibility are found to be excellent over the entire range of doses studied (0-28 Gy). A significant dose rate dependence is found for gels irradiated between 100-600 MU min⁻¹. Overall, the new gel is shown to have promising characteristics for CT PGD, however the implication of the observed dose rate dependence for some clinical applications remains to be determined. The new gel calibration method, based on pixel-by-pixel matching of dose and measured CT numbers, is found to be robust and to agree with the previously used region of interest technique. Pixel-by-pixel calibration is the new recommended standard for CT PGD. The dose resolution for the system was excellent, ranging from 0.2-0.5 Gy for doses between 0-20 Gy and 0.3-0.6 Gy for doses beyond 20 Gy. Comparison of the IMRT irradiation with planned doses yields excellent results: gamma pass rate (3%, 3 mm) of 99.3% at the isocentre slice and 93.4% over the entire treated volume.

This study compares prostate localization using three-dimensional ultrasound (3D US) to a standard technique using implanted fiducial markers (FMs) for prostate image guided radiation therapy (IGRT). Two methods to determine prostate position on US were evaluated: Assisted segmentation (prospectively) and manual segmentation (retrospectively). Daily couch shifts to align the prostate into treatment position were measured using each technique. A total of 278 FM couch shifts and 255 and 218 corresponding assisted and manual segmentation US couch shifts were analyzed in each direction: Anterior-posterior, right-left, and superior-inferior. Ninety five percent "limits-of-agreement" (LOA) were used to analyze paired couch shifts and to determine if US can reliably replace FMs. We chose an error tolerance of +/- 3 mm for the LOA analysis. For FM vs assisted-segmentation US, 35.3%, 51.0%, and 48.2% of couch shifts (anterior-posterior, right-left, and superior-inferior, respectively) agreed within +/- 3 mm. Agreement improved using manual segmentation US (corresponding agreements were 45.3%, 64.1%, and 55.2%), however, results still lie markedly below the 95% we consider to indicate clinical equivalence. Based on these results, our experience indicates US cannot replace FMs for prostate IGRT, using either assisted or manual segmentation. US couch shifts showed considerably greater variability than FM measures and US image quality is shown to affect agreement. Planning target volume margins for use with the US system were found to be 15.8, 8.7, and 12.5 mm for assisted segmentation and 13.1, 7.6, and 9.8 mm for manual segmentation. Comparison of these margins to those reported in recent studies for use with FM IGRT indicate FMs offer greater sparing of the rectum and bladder than the US system.

Multislice CT imaging has been evaluated for CT PGD and found to be the superior technique compared to single slice imaging in terms of the time required to complete a scan and the tube load characteristics associated with each scanning method. The implementation of multislice scanning is straightforward and expected to facilitate routine gel dosimetry measurements for complex dose distributions in modern RT centers.

In this work we investigate radiation dose rate dependencies of N-isopropylacrylamide (NIPAM) based polymer gel dosimeters (PGDs) used in conjunction with x-ray computed tomography imaging for radiotherapy dose verification. We define four primary forms of dose rate variation: constant mean dose rate where beam on and beam off times both vary, variable mean dose rate where beam on time varies, variable mean dose rate where beam off time varies and machine dose rate (MU min(-1)). We utilize both small (20 mL) vials and large volume (1L) gel containers to identify and characterize dose rate dependence in NIPAM PGDs. Results indicate that all investigated constant and variable mean dose rates had negligible affect on PGD dose response with the exception of machine dose rates (100-600 MU min(-1)) which produced variations in dose response significantly lower than previously reported. Explanations of the reduced variability in dose response are given. It is also shown that NIPAM PGD dose response is not affected by variations in dose rate that may occur in modulated treatment deliveries. Finally, compositional changes in NIPAM PGDs are investigated as potential mitigating strategies for dose rate-dependent response variability.

Purpose: To design and test an x‐ray CT polymer gel dosimetry system for 3D end‐to‐end dosimetry of brain and head and neck radiotherapy Methods: A head and neck phantom has been designed to undergo the entire RT process from immobilization and planning CT through to treatment. The phantom houses a 1L polymer gel in one of two locations: cranial and inferiorly in the neck region allowing for quality assurance of both brain and head and neck treatment processes. The gel dosimeter measures the delivered radiation dose in 3D, and following CT read‐out, provides a dose record of the entire treatment process, i.e. “end‐to‐end” dosimetry. Enhanced dose‐sensitivity N‐isopropylacrylamide (NIPAM) based gels along with an optimized CT protocol were used to minimize uncertainty in image CT numbers (H). Tests of phantom set‐up were performed to quantify image noise, uniformity and positioning reproducibility using locking bar (ideal conditions) and aquaplast mask (clinical conditions). The end‐to‐end dosimetry capability was tested by undertaking the full RT process (immobilization, planning CT, treatment planning, treatment set‐up and delivery) and comparing delivered and planned doses for a simple “star‐pattern” irradiation. Results: Removing the phantom head for gel read‐out minimized noise and artifacts (63% noise reduction), produced uniform images and has minimal impact on phantom re‐positioning (less than 0.5mm). Full phantom re‐positioning reproducibility was also excellent: less than 0.9 mm for both locking bar and mask immobilization. Initial end‐to‐end dosimetry tests indicate accurate localization of treatment dose to within 1 mm. Conclusions: An x‐ray CT polymer gel dosimetry system for performing 3D end‐to‐end dosimetry has been designed, tested and is demonstrated to provide accurate 3D localization of delivered radiation dose. Future work will assess clinical processes as undertaken by appropriate RT staff and look at other treatment sites.